Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes Mellitus

Table 3

Results from the binary logistic regression identifying variables which can predict response to exenatide therapy.

Variable	Odds ratio	95% confidence intervals	value
Age	0.977	0.942–1.01	0.20
Gender^*	1.07	0.502–2.26	0.87
Duration of diabetes (years)	0.972	0.913–1.04	0.38
Baseline weight (kg)	1.00	0.986–1.03	0.50
Baseline BMI (kg/m^2)	1.02	0.951–1.08	0.66
Baseline HbA1c (mmol/mol)	1.05	1.02–1.08	0.004
OHA only^**	1.48	0.267–8.17	0.66
Insulin only^**	8.33	1.03–67.1	0.046
OHAs and insulin^**	2.50	0.397–15.7	0.33

* denotes a variable that was compared against females; ** denotes a variable that was compared against exenatide as a monotherapy. BMI: body mass index; HbA1c: glycated haemoglobin; OHA: oral antihyperglycaemic agent.